Phathom Pharmaceuticals (PHAT) Other financing activities (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 7 years of Other financing activities data on file, last reported at $591000.0 in Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $591000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 98.72% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, up 2.44% from the prior year.
• Other financing activities for Q1 2026 stood at $591000.0, down from $1.3 million in the prior quarter.
• Over the last five years, Other financing activities for PHAT reached as high as $172.6 million in Q4 2023 and fell as low as $13000.0 in Q3 2023.
• Historically, Other financing activities has averaged $22.0 million across 4 years, with a median of $442000.0 in 2025.
• On a YoY basis, Other financing activities climbed as much as 2069.23% in 2024 and fell as far as 99.25% in 2024.
• Year by year, Other financing activities stood at $172.6 million in 2023, then plunged by 99.25% to $1.3 million in 2024, then decreased by 2.39% to $1.3 million in 2025, then slumped by 53.28% to $591000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $591000.0 in Q1 2026, $1.3 million in Q4 2025, and $293000.0 in Q3 2025.